We are exploring a new treatment called IPH5301, both alone and with chemotherapy and trastuzumab, for patients with advanced solid tumors. This study aims to understand how well it works and its safety in humans.
Health conditions and diseases that the clinical trial is designed to study and treat.
Advanced and metastatic cancer refers to cancer that has spread from its original site to other parts of the body. This includes various types such as breast, stomach, esophagus, pancreas, endometrium, ovary, and lung cancers, with specific focus on HER2-expressing cancers.
Locations and medical facilities where this clinical trial is currently recruiting or conducting research. Select the locations where you would like to participate.
Disclaimer: Parts of this content have been automatically extracted from the EU Clinical Trials registry. While we strive for accuracy, please always contact the trial site or sponsor directly for correct and official information before making any decisions about participation. View on EU Clinical Trials.